Antidote Health today announced the completion of a $22 million Series A funding round led by third-time investor iAngels, Group 11, and Flint Capital.

Providing affordable quality healthcare for all

The covid-19 pandemic has made telehealth a word that everyone is now familiar with. Telehealth, the use of digital information and communication technologies, such as computers and mobile devices, to access health care services remotely, was a way for consumers and providers to safely access and deliver healthcare as the pandemic rampaged through our communities. In April 2020, overall telehealth utilization for office visits and outpatient care was 78 times higher than in February 2020. This includes services from cardiology, dental/ oral, dermatology, general medicine, and more. Though the pandemic isn’t over, many are seeing the potential telehealth has, even in a post covid world; the U.S. healthcare market is laden with billions of dollars of operational and administrative inefficiencies, which leads to unaffordable and inaccessible healthcare for millions of Americans. Telehealth can therefore be a viable and affordable solution for many in need of healthcare.